Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients. - Hagemann K; Riecken K; Jung JM; Hildebrandt H; Menzel S; Bunders MJ; Fehse B; Koch-Nolte F; Heinrich F; Peine S; Schulze Zur Wiesch J; Brehm TT; et al. (European journal of immunology, 2022)